Patients’ retention strategies in clinical trials

2015 ◽  
Vol 62 (10) ◽  
pp. 475-477 ◽  
Author(s):  
Pedro Mezquita Raya ◽  
Rebeca Reyes García ◽  
Alejandra de Torres Sánchez
2003 ◽  
Vol 48 (7) ◽  
pp. 480-484 ◽  
Author(s):  
Daniele Zullino ◽  
Philippe Conus ◽  
François Borgeat ◽  
Charles Bonsack

Background: The feasibility of clinical trials depends, among other factors, on the number of eligible patients, the recruitment process, and the readiness of patients to participate in research. Seeking patients' views about their experience in research projects may allow investigators to develop more effective recruitment and retention strategies. Methods: A total of 100 patients consecutively admitted to a psychiatric university hospital were interviewed with respect to their willingness to participate in a study. For a different study scenario, patients were asked whether they would be ready to participate if such a study were organized in the service and to indicate their reasons for refusing or for participating. Results: The general readiness to participate in a study ranged between 70% and 96%. The prospect of remuneration did not notably augment the potential consent rate. The most common and spontaneous motivation for agreeing to take part in a study was to help science progress and to allow future patients to benefit from improved diagnosis and treatment (87%). The presence or lack of a financial incentive was rarely chosen as an argument to agree (23%) or to refuse (7%) to participate. Patients relied mainly on their treating physicians when contemplating possible participation in a study (family physician [65%] and hospital physician [54%]). Conclusions: Clinicians and, in particular, treating doctors can play an important role in facilitating the recruitment process.


Trials ◽  
2017 ◽  
Vol 18 (1) ◽  
Author(s):  
Anna Kearney ◽  
Anne Daykin ◽  
Alison R. G. Shaw ◽  
Athene J. Lane ◽  
Jane M. Blazeby ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 82-83
Author(s):  
Carol Musil ◽  
Britney Webster ◽  
Rachel Pruchno

Abstract Research aimed at testing readily delivered online psychosocial interventions for addressing the needs of custodial grandfamilies (CGF) has been scarce. This symposium reports on two NIH-funded randomized clinical trials (RCT) involving fully online interventions: Study 1 (S1)-dyadic social Intelligence training for custodial grandmothers and their adolescent grandchildren, and Study 2 (S2)-4 week resourcefulness training with daily journaling intervention for grandmothers only. We presented here on the unique advantages and challenges of online RCTs as they apply to CGFs and similar hard-to-reach populations. First, in a cross-study collaboration, Jeanblanc et al. report data from both studies on how COVID-19 influenced coping habits, grandchild’s remote learning, household conflict, uncertainty, and finances. Second, Castro et al. investigate how baseline positive and negative affect were reported in daily diaries completed by both grandmothers and grandchildren across 14 days at pretest in S1. Third, Musil et al. describe the challenges and benefits of using an entirely online design for the distribution and collection of longitudinal data, as exemplified by 4 weeks of qualitative daily journals from S2. Lastly, Webster et al. report on the benefits and challenges of recruitment and retention strategies encountered across S1 and S2. As discussant, Rachel Pruchno considers how the specific methodological advantages and disadvantages of online RCTs covered in the above papers apply to family caregiving research in general.


2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Adel Elfeky ◽  
Katie Gillies ◽  
Heidi Gardner ◽  
Cynthia Fraser ◽  
Timothy Ishaku ◽  
...  

Abstract Background Retention of participants is essential to ensure the statistical power and internal validity of clinical trials. Poor participant retention reduces power and can bias the estimates of intervention effect. There is sparse evidence from randomised comparisons of effective strategies to retain participants in randomised trials. Currently, non-randomised evaluations of trial retention interventions embedded in host clinical trials are rejected from the Cochrane review of strategies to improve retention because it only included randomised evaluations. However, the systematic assessment of non-randomised evaluations may inform trialists’ decision-making about retention methods that have been evaluated in a trial context.Therefore, we performed a systematic review to synthesise evidence from non-randomised evaluations of retention strategies in order to supplement existing randomised trial evidence. Methods We searched MEDLINE, EMBASE, and Cochrane CENTRAL from 2007 to October 2017. Two reviewers independently screened abstracts and full-text articles for non-randomised studies that compared two or more strategies to increase participant retention in randomised trials. The retention trials had to be nested in real ‘host’ trials ( including feasibility studies) but not hypothetical trials. Two investigators independently rated the risk of bias of included studies using the ROBINS-I tool and determined the certainty of evidence using GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework. Results Fourteen non-randomised studies of retention were included in this review. Most retention strategies (in 10 studies) aimed to increase questionnaire response rate. Favourable strategies for increasing questionnaire response rate were telephone follow-up compared to postal questionnaire completion, online questionnaire follow-up compared to postal questionnaire, shortened version of questionnaires versus longer questionnaires, electronically transferred monetary incentives compared to cash incentives, cash compared with no incentive and reminders to non-responders (telephone or text messaging). However, each retention strategy was evaluated in a single observational study. This, together with risk of bias concerns, meant that the overall GRADE certainty was low or very low for all included studies. Conclusions This systematic review provides low or very low certainty evidence on the effectiveness of retention strategies evaluated in non-randomised studies. Some strategies need further evaluation to provide confidence around the size and direction of the underlying effect.


2003 ◽  
Vol 1 (4) ◽  
pp. 269-276 ◽  
Author(s):  
Marwan N. Sabbagh ◽  
Nancy Thompson ◽  
Deborah Tweedy ◽  
Suhair Stipho-Majeed ◽  
Claudia Kawas ◽  
...  

Author(s):  
D. C. Swartzendruber ◽  
Norma L. Idoyaga-Vargas

The radionuclide gallium-67 (67Ga) localizes preferentially but not specifically in many human and experimental soft-tissue tumors. Because of this localization, 67Ga is used in clinical trials to detect humar. cancers by external scintiscanning methods. However, the fact that 67Ga does not localize specifically in tumors requires for its eventual clinical usefulness a fuller understanding of the mechanisms that control its deposition in both malignant and normal cells. We have previously reported that 67Ga localizes in lysosomal-like bodies, notably, although not exclusively, in macrophages of the spocytaneous AKR thymoma. Further studies on the uptake of 67Ga by macrophages are needed to determine whether there are factors related to malignancy that might alter the localization of 67Ga in these cells and thus provide clues to discovering the mechanism of 67Ga localization in tumor tissue.


2001 ◽  
Vol 120 (5) ◽  
pp. A284-A284
Author(s):  
B NAULT ◽  
S SUE ◽  
J HEGGLAND ◽  
S GOHARI ◽  
G LIGOZIO ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A410-A410
Author(s):  
T KOVASC ◽  
R ALTMAN ◽  
R JUTABHA ◽  
G OHNING

Sign in / Sign up

Export Citation Format

Share Document